Literature DB >> 15504885

SHV-49, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Klebsiella pneumoniae.

Véronique Dubois1, Laurent Poirel, Corinne Arpin, Laure Coulange, Cécile Bebear, Patrice Nordmann, Claudine Quentin.   

Abstract

A clinical strain of Klebsiella pneumoniae carried the bla(SHV-49) gene, encoding a novel inhibitor-resistant beta-lactamase of pI 7.6, derived from SHV-1 by the single substitution M69I. It also harbored a gene differing from bla(SHV-11) by four silent mutations and coding for a penicillinase. Both genes were chromosome located and might represent either a species-specific gene or an acquired resistance gene.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15504885      PMCID： PMC525401          DOI： 10.1128/AAC.48.11.4466-4469.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  Automated thermal cycling is superior to traditional methods for nucleotide sequencing of bla(SHV) genes.

Authors:  P A Bradford
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Molecular characterization of the SHV-11 beta-lactamase of Shigella dysenteriae.

Authors:  J Ahamed; M Kundu
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.

Authors:  L B Rice; L L Carias; A M Hujer; M Bonafede; R Hutton; C Hoyen; R A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.

Authors:  E E Prinarakis; V Miriagou; E Tzelepi; M Gazouli; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

6.  Molecular epidemiology of an outbreak due to IRT-2 beta-lactamase-producing strains of Klebsiella pneumoniae in a geriatric department.

Authors:  D Girlich; A Karim; L Poirel; M H Cavin; C Verny; P Nordmann
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

7.  First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.

Authors:  J Lemozy; D Sirot; C Chanal; C Huc; R Labia; H Dabernat; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.

Authors:  P Stapleton; P J Wu; A King; K Shannon; G French; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

9.  Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates.

Authors:  L Poirel; M Guibert; D Girlich; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 10.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132
View more
  13 in total

1.  Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.

Authors:  Véronique Dubois; Laurent Poirel; François Demarthe; Corinne Arpin; Laure Coulange; Luciene A R Minarini; Marie-Christine Bezian; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

2.  Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.

Authors:  Vera Manageiro; Eugénia Ferreira; Luís Albuquerque; Richard Bonnet; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

3.  Comment on: Resistance gene naming and numbering: is it a new gene or not?

Authors:  George A Jacoby; Robert A Bonomo; Patricia A Bradford; Karen Bush; Yohei Doi; Michael Feldgarden; Daniel Haft; William Klimke; Patrice Nordmann; Timothy Palzkill; Laurent Poirel; Arjun Prasad; Gian Maria Rossolini; Timothy Walsh
Journal:  J Antimicrob Chemother       Date:  2016-06-03       Impact factor: 5.790

Review 4.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

5.  Characterization of the inhibitor-resistant SHV β-lactamase SHV-107 in a clinical Klebsiella pneumoniae strain coproducing GES-7 enzyme.

Authors:  Vera Manageiro; Eugénia Ferreira; Antony Cougnoux; Luís Albuquerque; Manuela Caniça; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

6.  Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.

Authors:  Marisa L Winkler; Elizabeth A Rodkey; Magdalena A Taracila; Sarah M Drawz; Christopher R Bethel; Krisztina M Papp-Wallace; Kerri M Smith; Yan Xu; Jeffrey R Dwulit-Smith; Chiara Romagnoli; Emilia Caselli; Fabio Prati; Focco van den Akker; Robert A Bonomo
Journal:  J Med Chem       Date:  2013-02-04       Impact factor: 7.446

7.  Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.

Authors:  Joanna Empel; Anna Baraniak; Elzbieta Literacka; Agnieszka Mrówka; Janusz Fiett; Ewa Sadowy; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

8.  Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.

Authors:  Mei Li; Benjamin C Conklin; Magdalena A Taracila; Rebecca A Hutton; Marion J Skalweit
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 9.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.

Authors:  Nuno Mendonça; Vera Manageiro; Frédéric Robin; M José Salgado; Eugénia Ferreira; Manuela Caniça; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.